找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Interventional Therapies for Secondary and Essential Hypertension; Costas Tsioufis,Roland E. Schmieder,Giuseppe Manci Book 2016 Springer I

[復(fù)制鏈接]
查看: 24718|回復(fù): 55
樓主
發(fā)表于 2025-3-21 16:04:59 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Interventional Therapies for Secondary and Essential Hypertension
編輯Costas Tsioufis,Roland E. Schmieder,Giuseppe Manci
視頻videohttp://file.papertrans.cn/473/472988/472988.mp4
概述Focuses solely on interventional treatments of hypertension (secondary and essential).Offers a clear review of relevant procedures and guidance on their applications.Includes helpful explanatory diagr
叢書名稱Updates in Hypertension and Cardiovascular Protection
圖書封面Titlebook: Interventional Therapies for Secondary and Essential Hypertension;  Costas Tsioufis,Roland E. Schmieder,Giuseppe Manci Book 2016 Springer I
描述.This book aims to describe the role of interventional therapies in various forms of secondary hypertension and to explain the ability of such approaches to address unmet needs in the setting of uncontrolled essential hypertension. The coverage encompasses interventions in the full range of relevant conditions, including the various specific pathologies responsible for secondary hypertension, such as renal artery stenosis, coarctation of the aorta, and adrenal tumors. In each case, up-to-date information is presented on indications, procedural aspects, and patient follow-up. A further focus is the most recent knowledge on the use of invasive neuromodulation, such as renal sympathetic denervation and baroreflex stimulation. The text is supplemented by helpful explanatory diagrams and treatment algorithms. A comprehensive clinical guide of this nature has to date been absent from the literature. The book will be of interest to clinicians managing hypertensive patients, researchers investigating advanced hypertension management, and students on cardiovascular courses..
出版日期Book 2016
關(guān)鍵詞Resistant hypertension; Secondary hypertension; Renal artery stenosis; Hyperaldosteronism; Pheochromocyt
版次1
doihttps://doi.org/10.1007/978-3-319-34141-5
isbn_softcover978-3-319-81685-2
isbn_ebook978-3-319-34141-5Series ISSN 2366-4606 Series E-ISSN 2366-4614
issn_series 2366-4606
copyrightSpringer International Publishing Switzerland 2016
The information of publication is updating

書目名稱Interventional Therapies for Secondary and Essential Hypertension影響因子(影響力)




書目名稱Interventional Therapies for Secondary and Essential Hypertension影響因子(影響力)學(xué)科排名




書目名稱Interventional Therapies for Secondary and Essential Hypertension網(wǎng)絡(luò)公開度




書目名稱Interventional Therapies for Secondary and Essential Hypertension網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Interventional Therapies for Secondary and Essential Hypertension被引頻次




書目名稱Interventional Therapies for Secondary and Essential Hypertension被引頻次學(xué)科排名




書目名稱Interventional Therapies for Secondary and Essential Hypertension年度引用




書目名稱Interventional Therapies for Secondary and Essential Hypertension年度引用學(xué)科排名




書目名稱Interventional Therapies for Secondary and Essential Hypertension讀者反饋




書目名稱Interventional Therapies for Secondary and Essential Hypertension讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:31:11 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:48:13 | 只看該作者
Thomas Zeller MD,Ulrich Beschorner MD,Elias Noory MD
地板
發(fā)表于 2025-3-22 06:13:11 | 只看該作者
Maria Boutsikou MD, MSc, PhD,Anselm Uebing MD, PhD,Michael A. Gatzoulis MD, PhD, FACC, FESC
5#
發(fā)表于 2025-3-22 11:13:04 | 只看該作者
6#
發(fā)表于 2025-3-22 13:07:10 | 只看該作者
Atul Pathak MD, Phd,Benjamin Honton MD,Mel Lobo MD
7#
發(fā)表于 2025-3-22 18:28:02 | 只看該作者
8#
發(fā)表于 2025-3-22 23:00:07 | 只看該作者
9#
發(fā)表于 2025-3-23 04:35:34 | 只看該作者
Interventions for Renovascular Hypertensioned trials could prove a benefit of RAS revascularization compared to medical management. These negative trials including the CORAL trial had significant flaws in study design; crucial for a clinical benefit of revascularization of RAS is a proper patient selection, revascularization is only indicate
10#
發(fā)表于 2025-3-23 07:27:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-5 14:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
松桃| 宝坻区| 河津市| 钟祥市| 得荣县| 西充县| 宝鸡市| 鄯善县| 三亚市| 宁河县| 阳高县| 壤塘县| 平阳县| 明溪县| 延寿县| 梁河县| 旅游| 库尔勒市| 五家渠市| 施甸县| 宁津县| 麦盖提县| 盐山县| 兰州市| 阜新市| 垫江县| 中宁县| 康乐县| 昌图县| 宜州市| 白朗县| 卓资县| 贵溪市| 昌宁县| 红安县| 志丹县| 肃北| 太和县| 桐梓县| 镇沅| 陇川县|